| Christina Marsica Grassi, MD | |
|
330 Mt Auburn St, Mount Auburn Hospital, Cambridge, MA 02138 | |
| (617) 492-3500 | |
| Not Available |
| Full Name | Christina Marsica Grassi |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 330 Mt Auburn St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306228515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 264380 (Massachusetts) | Secondary |
| 207W00000X | Ophthalmology | 286348 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christina Marsica Grassi, MD Post Office Box 202, Winchester, MA 01890 Ph: () - | Christina Marsica Grassi, MD 330 Mt Auburn St, Mount Auburn Hospital, Cambridge, MA 02138 Ph: (617) 492-3500 |
News Archive
In this Lancet editorial, Giuseppe Raviola, Anne Becker and Paul Farmer, professors with the Department of Global Health and Social Medicine at Harvard Medical School, write, "Unprecedented opportunities to promote excellence and equity in health care delivery for the world's most underserved populations are upon us," but "delivery of mental health services in low-resource settings lags unacceptably and unjustly far behind that of other services."
Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.
The study, published on the preprint server bioRxiv*, highlights the need to study viral evolution and pathogenesis in human and animal hosts. This could help prevent future outbreaks that may mimic the magnitude of the current COVID-19 pandemic.
A study in experimental models suggests that allopregnanolone, one of many hormones produced by the placenta during pregnancy, is so essential to normal fetal brain development that when provision of that hormone decreases or stops abruptly - as occurs with premature birth - offspring are more likely to develop autism-like behaviors.
Yale Cancer Center researchers have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published in the Feb. 11 issue of the New England Journal of Medicine, could fundamentally change the way this cancer and others are treated.
› Verified 5 days ago
Kenneth A Stampfer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 625 Mount Auburn St, Suite 100, Cambridge, MA 02138 Phone: 617-492-1174 Fax: 617-492-6807 | |
Dr. Paul Barsam, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 725 Concord Ave, Cambridge, MA 02138 Phone: 617-864-8822 Fax: 617-864-9966 | |
Christopher C Robinson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 414, Cambridge, MA 02138 Phone: 617-876-3660 Fax: 617-876-2542 | |
Jeffrey L. Taveras, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Huhs, Cambridge, MA 02138 Phone: 617-495-2068 Fax: 617-496-0540 | |
Frank G Berson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 77 Massachusetts Ave, E23-2south, Cambridge, MA 02139 Phone: 617-253-4351 | |
Howard Ying, M.D.,PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5 Jfk St Ste 302, Cambridge, MA 02138 Phone: 617-657-9464 Fax: 617-491-0470 |